These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17220050)

  • 1. Effect of food on bioavailability of a single oral dose of clopidogrel in healthy male subjects.
    Nirogi RV; Kandikere VN; Mudigonda K
    Arzneimittelforschung; 2006; 56(11):735-9. PubMed ID: 17220050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioequivalence study of clopidogrel bisulfate film-coated tablets.
    Lainesse A; Ozalp Y; Wong H; Alpan RS
    Arzneimittelforschung; 2004 Sep; 54(9A):600-4. PubMed ID: 15497667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence study of two clopidogrel film-coated tablet formulations in healthy volunteers.
    Setiawati E; Yunaidi DA; Handayani LR; Santoso ID; Setiawati A; Tjandrawinata RR
    Arzneimittelforschung; 2011; 61(12):681-4. PubMed ID: 22282954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioequivalence study of two different clopidogrel bisulfate film-coated tablets.
    Richter W; Erenmemisoglu A; Van der Meer MJ; Emritte N; Tuncay E; Koytchev R
    Arzneimittelforschung; 2009; 59(6):297-302. PubMed ID: 19634511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clopidogrel bioavailability: absence of influence of food or antacids.
    McEwen J; Strauch G; Perles P; Pritchard G; Moreland TE; Necciari J; Dickinson JP
    Semin Thromb Hemost; 1999; 25 Suppl 2():47-50. PubMed ID: 10440423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects.
    Kim SD; Kang W; Lee HW; Park DJ; Ahn JH; Kim MJ; Kim EY; Kim SW; Nam HS; Na HJ; Yoon YR
    Clin Ther; 2009 Apr; 31(4):793-803. PubMed ID: 19446152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioequivalence of two tablet formulations of clopidogrel in healthy Argentinian volunteers: a single-dose, randomized-sequence, open-label crossover study.
    Di Girolamo G; Czerniuk P; Bertuola R; Keller GA
    Clin Ther; 2010 Jan; 32(1):161-70. PubMed ID: 20171421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic profile of 14C-labeled clopidogrel.
    Lins R; Broekhuysen J; Necciari J; Deroubaix X
    Semin Thromb Hemost; 1999; 25 Suppl 2():29-33. PubMed ID: 10440420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on bioavailability difference between clopidogrel bisulfate form I and form II using liquid chromatography/tandem mass spectrometry.
    Zou QG; Tan XH; Che WJ; Zhang ZJ; Wei P; Ou-Yang PK
    Arzneimittelforschung; 2011; 61(6):353-7. PubMed ID: 21827046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the pharmacokinetics of ticlopidine between administration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/ginkgo extract 80 mg, and concomitant administration of ticlopidine 250-mg and ginkgo extract 80-mg tablets: an open-label, two-treatment, single-dose, randomized-sequence crossover study in healthy Korean male volunteers.
    Kim TE; Kim BH; Kim J; Kim KP; Yi S; Shin HS; Lee YO; Lee KH; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Oct; 31(10):2249-57. PubMed ID: 19922896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of a co-formulated combination of amodiaquine and artesunate under fed and fasted conditions. A randomised, open-label crossover study.
    Fitoussi S; Thang C; Lesauvage E; Barré J; Charron B; Filali-Ansary A; Lameyre V
    Arzneimittelforschung; 2009; 59(7):370-6. PubMed ID: 19728565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clopidogrel pharmacodynamics and pharmacokinetics in the fed and fasted state: a randomized crossover study of healthy men.
    Hurbin F; Boulenc X; Daskalakis N; Farenc C; Taylor T; Bonneau D; Lacreta F; Cheng S; Sultan E
    J Clin Pharmacol; 2012 Oct; 52(10):1506-15. PubMed ID: 22128201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of clopidogrel in human plasma by sensitive liquid chromatography/tandem mass spectrometry.
    Nirogi RV; Kandikere VN; Shukla M; Mudigonda K; Maurya S; Boosi R
    Rapid Commun Mass Spectrom; 2006; 20(11):1695-700. PubMed ID: 16637000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative determination of clopidogrel active metabolite in human plasma by LC-MS/MS.
    Takahashi M; Pang H; Kawabata K; Farid NA; Kurihara A
    J Pharm Biomed Anal; 2008 Dec; 48(4):1219-24. PubMed ID: 18829199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of clopidogrel in human plasma by liquid chromatography/tandem mass spectrometry: application to a clinical pharmacokinetic study.
    Shin BS; Yoo SD
    Biomed Chromatogr; 2007 Sep; 21(9):883-9. PubMed ID: 17472221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.
    Kapil R; Nolting A; Roy P; Fiske W; Benedek I; Abramowitz W
    Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative bioavailability of two oral formulations of clopidogrel: determination of clopidogrel and its carboxylic acid metabolite (SR26334) under fasting and fed conditions in healthy subjects.
    Brvar N; Lachance S; Lévesque A; Breznik M; Cvitkovič Marčič L; Merslavič M; Grabnar I; Mateovič-Rojnik T
    Acta Pharm; 2014 Mar; 64(1):45-62. PubMed ID: 24670351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ranitidine on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel.
    Small DS; Farid NA; Li YG; Ernest CS; Payne CD; Salazar DE; Winters KJ
    Curr Med Res Opin; 2008 Aug; 24(8):2251-7. PubMed ID: 18786302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking behaviour modulates pharmacokinetics of orally administered clopidogrel.
    Yousef AM; Arafat T; Bulatova NR; Al-Zumyli R
    J Clin Pharm Ther; 2008 Aug; 33(4):439-49. PubMed ID: 18613862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of the parent compound determination in bioequivalence evaluation of clopidogrel generic products.
    Pawłowska M; Duda J; Tejchman-Małecka B; Bogiel M; Marzec A; Sieradzki E
    Arzneimittelforschung; 2009; 59(6):289-96. PubMed ID: 19634510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.